ALLISON HUTCHERSON: Open Payments
NPI 1104208883 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 23 payments from 8 companies in 2025. Trend: 2023 $293 · 2024 $38 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $157 |
| Gilead Sciences, Inc. | 4 | $111 |
| ViiV Healthcare Company | 2 | $52 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Grifols USA, LLC | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Octapharma USA, Inc. | 1 | $20 |
Products named: DALVANCE, NUZYRA, VOWST, DOVATO, Biktarvy, AVYCAZ, Gamunex-C, PIFELTRO.
Industry payments across TX — which companies pay providers there.
